Isomorphic Labs Appoints Ben Wolf as Chief Medical Officer, Expands to U.S. Hub in Cambridge
Isomorphic Labs has appointed Dr. Ben B. Wolf as Chief Medical Officer and opened a new U.S. office in Cambridge, …
News
Ryght AI Raises $3M to Automate Clinical Trial Site Activation with Agentic AI
Laguna Beach–based Ryght AI, co-founded by Simon Arkell and Alex Dickinson in mid-2023, develops agentic and generative AI tools to accelerate …
AstraZeneca Signs $5.3B AI Drug Discovery Deal with CSPC for Chronic Disease Programs
AstraZeneca has signed a licensing and co-discovery agreement with CSPC Pharmaceutical Group worth up to $5.3 billion, including $110 million …
Insilico Medicine Completes Oversubscribed Series E, Bringing Total Funding to $123 Million
Insilico Medicine has finalized its Series E round at $123 million, up from the $110 million first announced in March …
Sofinnova's Startups Get NVIDIA GPU Access to Accelerate Biological AI Models
Sofinnova Partners has announced a collaboration with NVIDIA to provide high-performance AI computing infrastructure to select companies in its life …
Insilico Medicine Launches its Multimodal Generative Chemistry Model on AWS Marketplace
Insilico Medicine has released Nach01, a large-scale generative chemistry foundation model, on the AWS Marketplace. The model combines structural and …
MIT and Recursion Launch Boltz-2, Open-Source AI Foundation Model for Structure and Binding Affinity Prediction
Researchers at MIT’s Jameel Clinic and CSAIL, in collaboration with Recursion and leveraging NVIDIA’s BioHive-2 supercomputer, have released Boltz-2, an …
FutureHouse Debuts Scientific Reasoning LLM Model Trained for Chemistry
FutureHouse has released ether0, a 24B-parameter open-weight language model specialized for chemistry tasks. Built on Mistral 24B Instruct and refined …
The Stage Is Set: London Biotechnology Show 2025
The inaugural London Biotechnology Show (LBS 2024) took place on 8–9 May 2024 at Olympia West, London, and culminated in …
Kiin Bio Raises $2.2M Pre-Seed to Build AI Platform of "Virtual Scientists" for Drug Discovery
Kiin Bio, a 2024-founded startup developing an AI-native research platform for drug discovery, has raised $2.2 million in pre-seed funding …
FDA Launches Internal AI Tool "Elsa" to Streamline Regulatory and Scientific Workflows
The U.S. Food and Drug Administration has deployed Elsa, an internal generative AI tool designed to assist employees with tasks …
Sarepta Secures First FDA Platform Designation for Gene Therapy Delivery Technology
The U.S. FDA has granted Platform Technology Designation to Sarepta Therapeutics’ rAAVrh74 viral vector, the delivery component used in SRP-9003, …